SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.025 (2.13%)
Bid:
1.15
Ask:
1.25
Spread: 0.10 (8.696%)
Market Cap: £19.27m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Genedrive News

Genedrive full-year revenue rises
29 Nov 2024

Genedrive full-year revenue rises

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive reported a significant increase in revenue in its full-year results on Frid...

AIM WINNERS & LOSERS: Botswana Diamonds shines; Peel Hunt slips
29 Nov 2024

AIM WINNERS & LOSERS: Botswana Diamonds shines; Peel Hunt slips

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

Genedrive annual loss widens due to increased expenses
29 Nov 2024

Genedrive annual loss widens due to increased expenses

(Alliance News - Genedrive PLC on Friday said its loss widened during its most recent financial year, as its expenses ramped up.

Director dealings: Genedrive chairman snaps up shares
15 Aug 2024

Director dealings: Genedrive chairman snaps up shares

(Sharecast News) - Genedrive revealed on Thursday that chairman Ian Gilham had acquired 1.0m shares in the AIM-listed pharmacogenetic testing company.

Genedrive makes first commercial sales of CYP2C19-ID testing kit
12 Aug 2024

Genedrive makes first commercial sales of CYP2C19-ID testing kit

(Sharecast News) - Pharmacogenetic testing firm Genedrive said on Monday that it has made the first UK commercial sales of its CYP2C19-ID testing kit.

LONDON BRIEFING: Bharti Global to build near 25% stake in BT
12 Aug 2024

LONDON BRIEFING: Bharti Global to build near 25% stake in BT

(Alliance News) - Stocks in London are called to open higher, as some calm spreads over markets a week after the global sell-off which shook investors...